A comprehensive view of Over-the-Counter (OTC) Products. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Teva recalls 715,682 bottles of Clear Eyes eye drops after product fails impurities test; recall involves lots 114349, expiration 05/2023; 117396, expiration 09/2023; 120128, expiration 11/2023; 114371, expiration 06/2023; 123781, expiration 02/2024
Published: March 22, 2023 by Miami Herald
Private-label OTC provider Granules Consumer Health completes audit by US FDA with zero 483 observations at its packaging facility in Manassas, Virginia; facility is spread over 79,000 sq. ft. and has several packaging suites to service customer needs
Published: March 22, 2023 by Dion Global Solutions Limited
Survey finds dramatic increase in demand for at-home diagnostic test kits over past two years; growth driven by rise in awareness of early diagnosis, increase in routine diagnosis, movement toward preventive care: R.R. Donnelley & Sons
Published: March 10, 2023 by Business Wire
Commentary: OTC at-home diagnostic testing has grown from nascent pre-pandemic trend to high-growth health product category, with COVID rapid tests marking tipping point; at-home testing kits market expected to grow at CAGR rate of 6.1% from 2022 to 2029
Published: March 06, 2023 by Chain Drug Review
FDA grants emergency use authorization to Lucira Health’s single0use OTC COVID-19 & Flu Home Test, the first test for both influenza and COVID-19; Lucira recently filed for bankruptcy
Published: March 03, 2023 by LiveScience

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count